{"id":1533,"date":"2012-02-01T12:06:00","date_gmt":"2012-02-01T11:06:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2012\/screening-auf-osteoporose-bei-frauen-ueber-67-jahre"},"modified":"2012-02-01T12:06:00","modified_gmt":"2012-02-01T11:06:00","slug":"screening-auf-osteoporose-bei-frauen-ueber-67-jahre","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2012\/screening-auf-osteoporose-bei-frauen-ueber-67-jahre","title":{"rendered":"Screening auf Osteoporose bei Frauen \u00fcber 67 Jahre"},"content":{"rendered":"<p>Messungen der Knochendichte mit der DXA (Dual-energy x-ray absorptiometry) nehmen zu, nicht zuletzt wegen der Empfehlungen verschiedener Fachgesellschaften, z.B. Deutsche Gesellschaft f\u00fcr Osteologie (1), US Preventive Services Task Force (2). Im N. Engl. J. Med. erschien nun eine Studie (3), die der Frage nachgeht, wann eine Wiederholung der Messung sinnvoll ist, wenn zuvor eine Osteoporose [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Messungen der Knochendichte mit der DXA (Dual-energy x-ray absorptiometry) nehmen zu, nicht zuletzt wegen der Empfehlungen verschiedener Fachgesellschaften, z.B. Deutsche Gesellschaft f\u00fcr Osteologie (1), US Preventive Services Task Force (2). Im N. Engl. J. Med. erschien nun eine Studie (3), die der Frage nachgeht, wann eine Wiederholung der Messung sinnvoll ist, wenn zuvor eine Osteoporose [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[2891,2013,357,3611,3610,362,70,359,3609],"class_list":["post-1533","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-frakturen","tag-frauen","tag-klimakterium","tag-knochen-mineralgehalt","tag-knochendichte","tag-menopause","tag-osteoporose","tag-postmenopause","tag-sof-studie"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1533","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=1533"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1533\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=1533"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=1533"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=1533"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}